hellotayssir/FinQA_TAT-QA_financial_finetuning_dataset huggingface dataset:
Restricted Stock Units
The 2013 Plan provides for the issuance of RSUs to employees, directors, and consultants. RSUs issued under the 2013 Plan generally vest over four years. A summary of activity of RSUs under the 2013 Plan at December 31, 2019 and changes during the periods then ended is presented in the following table:
As of December 31, 2019 and 2018, there was a total of $198.3 million and $107.9 million of unrecognized share-based compensation expense, net of estimated forfeitures, related to RSUs, which will be recognized on a straight-line basis over the remaining weighted-average vesting periods of approximately 2.3 years and 2.4 years, respectively.
Table:
 | Number of RSUs Outstanding (in thousands) | Weighted- Average Grant Date Fair Value Per Share | Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2016 | 3,554 | $18.01 | $73,261
Granted | 3,005 | 30.20 | 
Released | (1,680) | 19.54 | 
Canceled/Forfeited | (598) | 20.91 | 
Outstanding at December 31, 2017 | 4,281 | $25.51 | $207,197
Granted | 1,746 | 67.64 | 
Released | (1,971) | 30.50 | 
Canceled/Forfeited | (495) | 34.99 | 
Outstanding at December 31, 2018 | 3,561 | $42.09 | $293,523
Granted | 2,069 | 122.35 | 
Released | (1,906) | 50.99 | 
Canceled/Forfeited | (475) | 60.38 | 
Outstanding at December 31, 2019 | 3,249 | $85.39 | $548,145


Question: As of December 31 2019 and 2018, what are the respective values of unrecognized share-based compensation expense, net of estimated forfeitures, related to RSUs?
Answer: $198.3 million, $107.9 million
The activity for unrecognized gross tax benefits is as follows (in millions):
Included in the December 31, 2019 balance of $130.0 million is $97.2 million related to unrecognized tax benefits that, if recognized, would impact the annual effective tax rate. Also included in the balance of unrecognized tax benefits as of December 31, 2019 is $32.8 million of benefit that, if recognized, would result in adjustments to other tax accounts, primarily deferred taxes.
Although the Company cannot predict the timing of resolution with taxing authorities, if any, the Company believes it is reasonably possible that its unrecognized tax benefits will be reduced by $1.5 million in the next 12 months due to settlement with tax authorities or expiration of the applicable statute of limitations. The Company did not recognize any additional tax benefit or expense for interest and penalties during the year ended December 31, 2019.
The Company recognized approximately $0.8 million of tax benefit and $1.5 million of tax expense for interest and penalties during the years ended December 31, 2018 and 2017, respectively. The Company had approximately $5.1 million, $5.1 million, and $5.9 million of accrued interest and penalties at December 31, 2019, 2018, and 2017, respectively. The Company recognizes interest and penalties accrued in relation to unrecognized tax benefits in tax expense.
Tax years prior to 2016 are generally not subject to examination by the IRS except for items involving tax attributes that have been carried forward to tax years whose statute of limitations remains open. The Company is not currently under IRS examination. For state returns, the Company is generally not subject to income tax examinations for years prior to 2015.
The Company is also subject to routine examinations by various foreign tax jurisdictions in which it operates. With respect to jurisdictions outside the United States, the Company's subsidiaries are generally no longer subject to income tax audits for years prior to 2009. The Company is currently under audit in the following jurisdictions including, but not limited to, Canada, China, the Czech Republic, the Philippines, Singapore and the United Kingdom.
Table:
 | 2019 | 2018 | 2017
Balance at beginning of year | $112.2 | $114.8 | $136.7
Acquired balances | 15.5 | — | —
Additions for tax benefits related to the current year | 9.4 | 7.4 | 23.6
Additions for tax benefits of prior years | 8.0 | 2.8 | 4.7
Reductions for tax benefits of prior years | (0.2) | (1.9) | (1.6)
Lapse of statute | (8.2) | (10.9) | (16.3)
Settlements | (6.7) | — | (4.9)
Change in rate due to U.S. Tax Reform | — | — | (27.4)
Balance at end of year | $130.0 | $112.2 | $114.8


Question: What is the change in Lapse of statute from year ended December 31, 2018 to 2019?
Answer: 2.7
Calculation: -8.2-(10.9)
Our net sales by offering category for EMEA for 2019 and 2018, were as follows (dollars in thousands):
Net sales in EMEA remained flat (increased 5% excluding the effects of fluctuating foreign currency exchange rates), or down $3.6 million, in 2019 compared to 2018. Net sales of hardware declined 5%, year to year, while net sales of software and services were up 2% and 7%, respectively, year over year. The changes were the result of the following:
• Lower volume of net sales of networking solutions, partially offset by higher volume of net sales of devices, to large enterprise and public sector clients in hardware net sales. • Higher volume of software net sales to large enterprise and public sector clients.
• Higher volume of net sales of cloud solution offerings and increased software referral fees that are recorded on a net sales recognition basis. In addition, there was an increase in the volume of Insight delivered services.
Table:
 | EMEA |  | 
Sales Mix | 2019 | 2018 | %Change
Hardware | $622,949 | $653,499 | (5%)
Software | 753,729 | 736,509 | 2%
Services | 149,966 | 140,233 | 7%
 | $1,526,644 | $1,530,241 | —


Question: What is the change in Sales Mix of Software between 2018 and 2019?
Answer: 17220
Calculation: 753,729-736,509
NOTE 9. ACCOUNTS RECEIVABLE
A significant percentage of our accounts receivable is derived from sales to a limited number of large multinational semiconductor device manufacturers located throughout the world. In order to monitor potential expected credit losses, we perform ongoing credit evaluations of our customers’ financial condition.
The carrying amount of accounts receivable is as follows:
Table:
 | December 31, | 
 | 2018 | 2019
Current | 154,607 | 171,866
Overdue <30 days | 8,802 | 19,977
Overdue 31-60 days | 2,258 | 2,076
Overdue 61-120 days | 3,507 | 1,599
Overdue >120 days | 4,276 | 4,017
Total | 173,450 | 199,535


Question: What are the time frames of carrying amount of accounts receivable?
Answer: Current, Overdue <30 days, Overdue 31-60 days, Overdue 61-120 days, Overdue >120 days
Operating profit/loss
Our operating profit in 2019 was EUR 485 million, a change of EUR 544 million, compared to an operating loss of EUR 59 million in 2018. The change in operating result was primarily due to lower selling, general and administrative expenses, research and development expenses and a net positive fluctuation in other operating income and expenses, partially offset by lower gross profit. Our operating margin in 2019 was 2.1%, compared to approximately breakeven in 2018.
(1) Excludes costs related to the acquisition of Alcatel Lucent and related integration, goodwill impairment charges, intangible asset amortization and other purchase price fair value adjustments, restructuring and associated charges and certain other items.
The following table sets forth the impact of unallocated items on operating profit/loss:
Table:
EURm | 2019 | 2018
Total segment operating profit(1) | 2,003 | 2,180
Amortization and depreciation of acquired intangible assets and property, plant and equipment | (924) | (940)
Restructuring and associated charges | (502) | (321)
Gain on defined benefit plan amendment | 168 | -
Product portfolio strategy costs | (163) | (583)
Transaction and related costs, including integration costs relating to the acquisition of Alcatel Lucent | (48) | (220)
Impairment of assets, net of impairment reversals | (29) | (48)
Operating model integration | (12) | -
Release of acquisition-related fair value adjustments to deferred revenue and inventory | (6) | (16)
Divestment of businesses | (2) | (39)
Fair value changes of legacy IPR fund | - | (57)
Other | - | (15)
Total operating profit/(loss) | 485 | (59)


Question: What is excluded from Total segment operating profit?
Answer: costs related to the acquisition of Alcatel Lucent and related integration, goodwill impairment charges, intangible asset amortization and other purchase price fair value adjustments, restructuring and associated charges and certain other items.
24. EARNINGS PER SHARE
The following table set forth the computation for basic and diluted net income (loss) per share of common stock (in thousands, except per share data):
As of September 27, 2019, we had warrants outstanding which were reported as a liability on the consolidated balance sheet. During fiscal years 2019 and 2018, we recorded gains of $0.8 million and $27.6 million, respectively, associated with adjusting the fair value of the warrants, in the Consolidated Statements of Operations primarily as a result of declines in our stock price.
When calculating earnings per share we are required to adjust for the dilutive effect of outstanding common stock equivalents, including adjustment to the numerator for the dilutive effect of contracts that must be settled in common stock. During the fiscal year ended September 27, 2019, we excluded the effects of the warrant gain and the 214,303 of potential shares of common stock issuable upon exercise of warrants as the inclusion would be anti-dilutive.
During the fiscal year ended September 28, 2018, we adjusted the numerator to exclude the warrant gain $27.6 million, and we also adjusted the denominator for the dilutive effect of the incremental warrant shares of 569,667 under the treasury stock method. For the fiscal years 2018, the table above excludes the effects of 375,940 shares of potential shares of common stock issuable upon exercise of stock options, restricted stock and restricted stock units as the inclusion would be anti-dilutive.
The table excludes the effects of 386,552 and 1,877,401 shares for fiscal years 2019 and 2017, respectively, of potential shares of common stock issuable upon exercise of stock options, restricted stock, restricted stock units and warrants as the inclusion would be anti-dilutive.
Table:
 |  | Fiscal Years | 
 | 2019 | 2018 | 2017
Numerator:      |  |  | 
Loss from continuing operations | $(383,798) | $(133,762) | $(150,416)
Loss from discontinued operations | — | (6,215) | (19,077)
Net loss | (383,798) | (139,977) | (169,493)
Warrant liability gain | — | (27,646) | —
Net loss attributable to common stockholders | $(383,798) | $(167,623) | $(169,493)
Denominator:      |  |  | 
Weighted average common shares outstanding-basic | 65,686 | 64,741 | 60,704
Dilutive effect of warrants | — | 570 | —
Weighted average common shares outstanding-diluted | 65,686 | 65,311 | 60,704
Common stock earnings per share-basic:      |  |  | 
Continuing operations | $(5.84) | $(2.07) | $(2.48)
Discontinued operations | — | (0.10) | (0.31)
Net common stock earnings per share-basic | $(5.84) | $(2.16) | $(2.79)
Common stock earnings per share-diluted: |  |  | 
Continuing operations | $(5.84) | $(2.47) | $(2.48)
Discontinued operations | — | (0.10) | (0.31)
Net common stock earnings per share-diluted | $(5.84) | $(2.57) | $(2.79)


Question: In which year was Loss from discontinued operations 0?
Answer: 2019
Calculation: locate and analyze Loss from discontinued operations in row 5
The following table reconciles the expected income tax expense, computed by applying our combined German tax rate of 26.4% (2018: 26.4%; 2017: 26.4%), to the actual income tax expense. Our 2019 combined German tax rate includes a corporate income tax rate of 15.0% (2018: 15.0%; 2017: 15.0%), plus a solidarity surcharge of 5.5% (2018: 5.5%; 2017: 5.5%) thereon, and trade taxes of 10.6% (2018: 10.6%; 2017: 10.6%).
Relationship Between Tax Expense and Profit Before Tax
Table:
€ millions, unless otherwise stated | 2019 | 2018 | 2017
Profit before tax | 4,596 | 5,600 | 5,029
Tax expense at applicable tax rate of 26.4% rate of 26.4% (2018: 26.4%; 2017: 26.4%) | 1,212 | 1,478 | 1,327
Tax effect of: |  |  | 
Foreign tax rates | –209 | –147 | –403
Changes in tax laws and tax rates | 10 | 0 | –212
Non-deductible expenses | 116 | 106 | 82
Tax-exempt income | –93 | –38 | –95
Withholding taxes | 138 | 91 | 131
Research and development and foreign tax credits | –89 | –33 | –26
Prior-year taxes | 80 | –17 | –26
Reassessment of deferred tax assets, research and development tax credits, and foreign tax credits | 48 | 58 | 185
Other | 13 | 13 | 20
Total income tax expense | 1,226 | 1,511 | 983
Effective tax rate (in %) | 26.7 | 27.0 | 19.5


Question: What was the applicable tax rate in 2018?
Answer: 26.4%
The provision for income taxes differed from the provision computed by applying the Federal statutory rate to income (loss) from continuing operations before taxes due to the following:
The effective income tax rate was 18.9% and (141.8)% during the years ended December 31, 2019 and December 31, 2018, respectively. The decrease in 2019 compared to statutory tax rate of 21% was primarily due to deferred tax adjustments related to foreign tax credit carryforwards and state taxes, offset by changes in the valuation allowance and excess tax benefits resulting from the exercise of non-qualified stock options.
The effective tax rate for the year ended December 31,2018 was significantly impacted by recording a substantial increase in a valuation allowance on the entire deferred tax assets.
Table:
 | Year ended December 31, | 
 | 2019 | 2018
Federal statutory tax rate | 21.0% | 21.0%
State taxes | (4.5) | 4.4
Non deductible expenses | (0.3) | (0.6)
Tax credits | 4.0 | 4.6
Expired tax credit | (1.3) | (3.9)
Deferred tax adjustment | (4.8) | —
Stock based compensation | 1.9 | 0.8
Valuation allowance | 3.2 | (167.0)
Contingent purchase revaluation | — | (1.0)
Other | (0.3) | (0.1)
 | 18.9% | (141.8)%


Question: What impacted the effective tax rate for the year ended December 31, 2018?
Answer: by recording a substantial increase in a valuation allowance on the entire deferred tax assets.
A summary of options outstanding and vested as of December 31, 2019 is as follows:
The total intrinsic value of options exercised during 2019, 2018, and 2017 was $318.5 million, $17.4 million, and $6.6 million, respectively.
The weighted average grant date fair value of options granted during the years ended December 31, 2019, 2018, and 2017, was $19.80, $9.07, and $6.44 per share, respectively. During the year ended December 31, 2019, 2,141,078 options vested. There were 2,939,947 options unvested as of December 31, 2019.
As of December 31, 2019, $30.3 million of total unrecognized compensation cost related to stock options was expected to be recognized over a weighted average period of approximately 2.5 years.
Table:
 | Options Outstanding |  | Options Vested and Exercisable | 
Exercise Prices | Number Outstanding | Weighted Average Life (in Years) | Number Vested and Exercisable | Weighted Average Life (in Years)
$1.50 to $1.90 | 32,913 | 1.4 | 32,913 | 1.4
2.86 to 6.40 | 209,126 | 3.3 | 209,126 | 3.3
8.04 to 11.72 | 498,869 | 4.2 | 498,869 | 4.2
12.20 to 15.06 | 2,227,421 | 6.7 | 1,587,924 | 6.5
16.06 to 24.00 | 1,772,062 | 8.1 | 560,632 | 8.1
31.99 to 42.21 | 847,010 | 9.0 | 42,839 | 8.7
55.10 to 79.25 | 297,341 | 9.5 | 12,492 | 9.3
 | 5,884,742 |  | 2,944,795 | 


Question: What is the number of outstanding options whose exercise price are between $1.50 to $6.40?
Answer: 242039
Calculation: 32,913 + 209,126
General and Administrative Expenses: General and administrative expenses primarily consist of personnel related expenditures for IT, finance, legal and human resources support functions; and professional services fees.
(1) Excluding stock-based compensation
Excluding the effects of currency rate fluctuations, total general and administrative expenses increased in fiscal 2019 compared to fiscal 2018 primarily due to increased professional services fees
Table:
Year Ended May 31, |  |  |  | 
 |  |  | Percent Change | 
(Dollars in millions) | 2019 | Actual | Constant | 2018
General and administrative (1) | $1,093 | -1% | 2% | $1,102
Stock-based compensation | 172 | -5% | -5% | 180
Total expenses | $1,265 | -1% | 1% | $1,282
% of Total Revenues | 3% |  |  | 3%


Question: Which month did the financial year end in 2019?
Answer: Year Ended May 31
In 2019 we recorded $5 million of impairment, restructuring charges and other related closure costs, mainly consisting of impairment of equipment and licenses dedicated exclusively to certain development projects that were cancelled, while no alternative future use was identified internally.
In 2018 we recorded $21 million of impairment, restructuring charges and other related closure costs, consisting of: (i) $19 million related to the set-top box restructuring plan and (ii) $2 million of impairment of acquired technologies, for which it was determined that they had no future alternative use.
In 2017 we recorded $45 million of impairment, restructuring charges and other related closure costs, primarily consisting of: (i) $34 million of net restructuring charges related to the set-top box restructuring plan; (ii) $13 million of restructuring charges related to the restructuring plan in Bouskoura, Morocco;
(iii) $3 million charge relating to the update of the existing unused lease provision and (iv) $5 million income for the reversal of provisions related to previously announced restructuring plans, mainly the Embedded Processing Solutions business restructuring plan, for which accrued provisions were not fully used at completion of the plan.
Table:
 |  | Year Ended December 31, | 
 | 2019 | 2018 | 2017
 |  | (In millions) | 
Impairment, restructuring charges and other related closure costs | $(5) | $(21) | $(45)


Question: What is the increase/ (decrease) in Impairment, restructuring charges and other related closure costs from 2017 to 2019?
Answer: -40
Calculation: 5-45
The following table illustrates the classification of pre-payroll tax and social contribution stock-based compensation expense included in the consolidated statements of income for the years ended December 31, 2019, December 31, 2018 and December 31, 2017:
The fair value of the shares vested in 2019 was $114 million compared to $68 million for 2018 and $38 million for 2017.
Compensation cost, excluding payroll tax and social contribution, capitalized as part of inventory was $6 million as of December 31, 2019, compared to $6 million as of December 31, 2018 and $3 million as of December 31, 2017. As of December 31, 2019, there was $138 million of total unrecognized compensation cost related to the grant of unvested shares, which is expected to be recognized over a weighted average period of approximately 9 months.
The total deferred income tax benefit recognized in the consolidated statements of income related to unvested share-based compensation expense amounted to $9 million, $7 million and $3 million for the years ended December 31, 2019, 2018 and 2017, respectively.
Table:
 | December 31, 2019 | December 31, 2018 | December 31, 2017
Cost of sales | 22 | 23 | 12
Selling, general and administrative | 46 | 67 | 31
Research and development | 77 | 35 | 18
Total pre-payroll tax and social contribution compensation | 145 | 125 | 61


Question: What was the increase ./ (decrease) in the cost of sales from 2018 to 2019?
Answer: -1
Calculation: 22 - 23
The following table reconciles the theoretical corporation tax expense to the reported tax expense using the UK corporation tax rate. The reconciling items represent the impact of rate differentials in tax jurisdictions and the impact of non-taxable benefits and non-deductible expenses arising from differences between the local tax base and the reported Financial Statements.
The Group’s taxation strategy is published at www.sophos.com/en-us/medialibrary/PDFs/legal/sophos-group-tax-poli
The Group’s taxation strategy is published at www.sophos.com/en-us/medialibrary/PDFs/legal/sophos-group-tax-policyfy19. pdf and is aligned to its business strategy and operational needs. Oversight of taxation is within the remit of the Audit and Risk Committee. The Chief Financial Officer is responsible for tax strategy supported by a global team of tax professionals. Sophos strives for an open and transparent relationship with all revenue authorities and is vigilant in ensuring that the Group complies with current tax legislation. The Group proactively seeks to agree arm’s length pricing with tax authorities to mitigate tax risks of significant cross-border operations. The Group actively engages with policy makers, tax administrators, industry bodies and international institutions to provide informed input on proposed tax measures, so that it and they can understand how those proposals would affect the Group. However, a tax authority may seek adjustment to the filing position adopted by a Group company and it is accepted that interpretation of complex regulations may lead to additional tax being assessed. Uncertain tax positions are monitored regularly and a provision made in the accounts where appropriate.
Table:
 | Year-ended 31 March 2019 | Year-ended 31 March 2018 Restated See note 2
 | $M | $M
Profit / (loss) for the year before taxation | 53.6 | (41.0)
Loss for the year before taxation multiplied by the standard rate of corporation tax in the UK of 19% (2018: 19%) | 10.2 | (7.7)
Effects of: |  | 
Adjustments in respect of previous years | 0.8 | 7.1
Change in tax rate during the year | 1.4 | 3.6
Expenses not deductible for tax purposes | 11.8 | 9.4
Losses not recognised | (0.9) | –
Higher tax rates on overseas earnings | 7.7 | 3.8
Research and development and other tax credits | (1.9) | (0.6)
Impact of US tax reform on deferred tax | – | 5.4
Other movements | (2.4) | (1.1)
Charge for taxation on profit / (loss) for the year | 26.7 | 19.9


Question: What is the Chief Financial Officer responsible for?
Answer: responsible for tax strategy supported by a global team of tax professionals. Sophos strives for an open and transparent relationship with all revenue authorities and is vigilant in ensuring that the Group complies with current tax legislation.